Palisade Bio, Inc.
PALINASDAQHealthcareBiotechnology
Regular session
$2.025
−$0.075 · -3.57%
PALI company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
58
Fair Value
Momentum
49
Neutral
Sentiment
69
Bullish
Risk resilience
36
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websitePalisade Bio, Inc. is a clinical-stage biopharmaceutical firm dedicated to identifying, advancing, and bringing to market orally administered treatments for significant conditions stemming from a compromised gastrointestinal mucosal barrier. The company's primary therapeutic candidate, LB1148, is an oral liquid formulation designed to inhibit digestive enzymes. Its goal is to safeguard gut integrity when the intestine experiences stress due to factors such as diminished blood supply, infections, or surgical procedures. Established in 2005, the company maintains its headquarters in Carlsbad, California.
- Industry
- Biotechnology
- Sector
- Healthcare
- Headquarters
- US
- CEO
- J. D. Finley
- Listed since
- Mar 30, 2007
- Employees
- 14
Market position
Day range
Current $2.025
52-week range
Current $2.025
- Open
- $2.05
- Previous close
- $2.10
- Volume
- 726.46K
- 0.22× average
- Average volume
- 3.28M
- Average daily volume
- Market cap
- 351.5M USD
- Beta
- 1.54
- Market reference 1
- 50-day average
- $1.9816
- +2.19% above average
- 200-day average
- $1.9358
- +4.61% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- -2.49M USD
- P/E (TTM)
- -3.81×
- P/B (TTM)
- 3.52×
- P/S (TTM)
- 703×
- EV / EBITDA
- 0.15×
- Earnings yield
- -12.83%
- Free cash flow yield
- -8.29%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 100.00%
- Operating margin
- -7069.80%
- Net margin
- -6388.20%
- Return on equity
- -12.97%
- Return on assets
- -12.49%
- Return on invested capital
- -13.91%
Financial health
- Debt / equity
- 0×
- Current ratio
- 28.95×
Earnings
- EPS beat rate
- 45%
- 5 beats, 6 misses, 0 met estimates
- Average EPS surprise
- -7.94%
- 11 comparable reports
- Latest EPS result
- -0.05
- Estimate -0.05 · Beat by 4.25%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$4.50
122.22% upsidePrice history unavailable
High $7.00Average $4.50Low $2.00Rating distribution
3 ratingsLimited analyst sample: 3 ratings. Interpret the distribution with caution.
PALI news
Corporate actions
Corporate action history
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Apr 8, 2024 | 1:15 | — | — |
Stock split | Nov 16, 2022 | 1:50 | — | — |
Stock split | Apr 28, 2021 | 1:6 | — | — |
Stock split | Jul 18, 2019 | 1:20 | — | — |
Stock split | Jan 9, 2017 | 1:13 | — | — |
Effective Apr 8, 2024
1:15
Effective Nov 16, 2022
1:50
Effective Apr 28, 2021
1:6
Effective Jul 18, 2019
1:20
Effective Jan 9, 2017
1:13
PALI peers
ETFs holding PALI
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Russell 2000 ETFIWM7.67M0.01%81.62B USD0.19%$298.44-0.51%
Vanguard Extended Market ETFVXF3.27M0.00%93.7B USD0.05%$243.77-0.72%
iShares Russell 2000 Value ETFIWN2.33M0.02%14.66B USD0.24%$224.96+0.06%
Vanguard Russell 2000 ETFVTWO1.57M0.01%17.4B USD0.06%$120.66-0.49%
iShares Micro-Cap ETFIWC1.07M0.07%1.53B USD0.60%$196.84-0.65%
Simplify Propel Opportunities ETFSURI912.1K1.07%85.05M USD2.82%$19.70-0.60%
iShares Core S&P Total U.S. Stock Market ETFITOT807.45K0.00%97.17B USD0.03%$167.27-0.42%
iShares Russell 2000 Growth ETFIWO516.79K0.00%15.16B USD0.24%$383.06-1.11%iShares Russell 2000 ETFIWM- Market value
- 7.67M
- Weight
- 0.01%
- AUM
- 81.62B USD
- Expense ratio
- 0.19%
- Price / 1D
- $298.44-0.51%
Vanguard Extended Market ETFVXF- Market value
- 3.27M
- Weight
- 0.00%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $243.77-0.72%
iShares Russell 2000 Value ETFIWN- Market value
- 2.33M
- Weight
- 0.02%
- AUM
- 14.66B USD
- Expense ratio
- 0.24%
- Price / 1D
- $224.96+0.06%
Vanguard Russell 2000 ETFVTWO- Market value
- 1.57M
- Weight
- 0.01%
- AUM
- 17.4B USD
- Expense ratio
- 0.06%
- Price / 1D
- $120.66-0.49%
iShares Micro-Cap ETFIWC- Market value
- 1.07M
- Weight
- 0.07%
- AUM
- 1.53B USD
- Expense ratio
- 0.60%
- Price / 1D
- $196.84-0.65%
Simplify Propel Opportunities ETFSURI- Market value
- 912.1K
- Weight
- 1.07%
- AUM
- 85.05M USD
- Expense ratio
- 2.82%
- Price / 1D
- $19.70-0.60%
iShares Core S&P Total U.S. Stock Market ETFITOT- Market value
- 807.45K
- Weight
- 0.00%
- AUM
- 97.17B USD
- Expense ratio
- 0.03%
- Price / 1D
- $167.27-0.42%
iShares Russell 2000 Growth ETFIWO- Market value
- 516.79K
- Weight
- 0.00%
- AUM
- 15.16B USD
- Expense ratio
- 0.24%
- Price / 1D
- $383.06-1.11%
Continue in GoAI
Research PALIresearch.disclaimer